CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook

EarningsARCALYSTPositive
AI Analysis

Summary

Kiniksa Pharmaceuticals reported Q2 2026 earnings with a raised sales outlook for its ARCALYST drug product.

Financial Highlights

Guidance

higher ARCALYST sales outlook

Importance:5/10
Sentiment:
0.60
earningsguidancedrug salesQ2 2026
Related Companies

Read the original article

Published by yahoo_finance on August 3, 2026 2:00 PM

Read Original